These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34181196)

  • 1. Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
    Geetha D; Attarwala N; Zhang C; Kant S; Antiochos B; Seo P; Le A
    J Nephrol; 2022 Mar; 35(2):657-663. PubMed ID: 34181196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics combined with clinical analysis explores metabolic changes and potential serum metabolite biomarkers of antineutrophil cytoplasmic antibody-associated vasculitis with renal impairment.
    Liu S; Xu Q; Wang Y; Lv Y; Liu QQ
    PeerJ; 2023; 11():e15051. PubMed ID: 36942002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ETAR and suPAR as markers of disease activity in renal ANCA-associated vasculitis.
    Rowaiye OO; Kusztal M; Zabinska M; Bartoszek D; Myszka M; Kościelska-Kasprzak K; Banasik M; Mazanowska O; Klinger M; Krajewska M
    Adv Med Sci; 2022 Mar; 67(1):23-28. PubMed ID: 34781174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
    Ahn SS; Kim JO; Yoon T; Song JJ; Park YB; Lee SW; Park SG
    Biomed Res Int; 2019; 2019():7508240. PubMed ID: 31236412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Lieberthal JG; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA; Monach PA;
    J Rheumatol; 2013 May; 40(5):674-83. PubMed ID: 23547217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study.
    Morris AD; Freitas DLD; Lima KMG; Floyd L; Brady ME; Dhaygude AP; Rowbottom AW; Martin FL
    Molecules; 2022 Apr; 27(7):. PubMed ID: 35408711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study.
    Ahn SS; Yoon T; Park YB; Prendecki M; Bhangal G; McAdoo SP; Lee SW
    Arthritis Res Ther; 2021 Mar; 23(1):77. PubMed ID: 33685523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
    Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
    Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
    de Souza AW; Abdulahad WH; Sosicka P; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
    Clin Exp Immunol; 2014 Nov; 178(2):270-8. PubMed ID: 25052363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
    Shah S; Havill J; Rahman MH; Geetha D
    Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.
    Maruyama H; Hirayama K; Nagai M; Ebihara I; Shimohata H; Kobayashi M
    Clin Rheumatol; 2016 Oct; 35(10):2469-76. PubMed ID: 27251675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological features of patients with antineutrophil cytoplasmic antibody-associated vasculitides concomitant with IgG4-related disease.
    Ma Y; Chen L; Xu Y; Han Q; Yu B; Yuan Y; Zhao J; Yang Y; Chen J; Han F
    Int J Rheum Dis; 2019 Dec; 22(12):2143-2150. PubMed ID: 31631507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
    Front Immunol; 2021; 12():625672. PubMed ID: 33841408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report.
    Li XL; Xu PC; Chen T; Yan TK; Jiang JQ; Jia JY; Wei L; Shang WY; Hu SY
    Medicine (Baltimore); 2017 Dec; 96(51):e9128. PubMed ID: 29390440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():736638. PubMed ID: 34630417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.